BackEQ Health Acquisition Overview

EQ Health Acquisition EBIT

EQ Health Acquisition's EBIT is $1.5M, above the sector sector average of $-63M.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$205.99K
70.16% YoY

As of Sep 30, 2022

Annual EBIT (TTM)

$1.48M
152.56% YoY

Trailing 12 months ending Sep 30, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

EQ Health Acquisition (EQHA) FAQ

The latest EBIT for EQHA is $1.5M as of September 2022. That compares with $-2.8M in the prior-year period — up 152.6% year over year. That is above the sector sector average of $-63M. Investors often review this figure alongside EQ Health Acquisition's historical trend and sector peers before judging valuation or financial health.

Over the past year, EQHA's EBIT moved from $-2.8M to $1.5M — a 152.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in EQ Health Acquisition's operating scale or balance-sheet position.

Against its sector companies, EQHA currently prints $1.5M for EBIT, while the sector average sits near $-63M. That is roughly 102.4% above the sector mean. Large gaps often invite a closer look at EQ Health Acquisition's growth, margins, and balance sheet.

A EBIT figure of $1.5M for EQHA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-63M. Explore the charts below for those layers of context.

After noting EQHA's EBIT ($1.5M), review year-over-year change from $-2.8M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.